INO-8000

N/A

Report date: 2022/12/16 16:46:46

Base Information

Drug NameINO-8000
Drug Alias NameINO-8000VGX-6150
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionHepatitis C virus serine protease, NS3/NS4A inhibitorsNonstructural protein 4B inhibitorsNonstructural protein 5A inhibitors
TargetsHepatitis C virus serine protease, NS3/NS4ANonstructural protein 4BNonstructural protein 5A
Therapy Area/IndicationsHepatitis C, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGeneone Life Science Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C, Chronic

Other Information

ATC CodeN/A
Related LinksN/A